FDA Inspection 770193 — UCH-MHS

UCH-MHS — FEI 1770154

The FDA completed an inspection of UCH-MHS on March 1, 2012 in Colorado Springs, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 28 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 1, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Colorado Springs, CO (United States)

Citations

IDCFRDescription
10121 CFR 606.110(a)Supervision of qualified physician
10221 CFR 606.110(a)Written certification
110521 CFR 211.22(d)Procedures not in writing, fully followed
113321 CFR 211.25(a)GMP Training Frequency
1220321 CFR 606.170(a)Adverse Reaction- Reports of Investigations
15421 CFR 606.160(a)(1)Concurrent documentation
15521 CFR 606.160(b)Required records
15821 CFR 606.160(e)(1)Donor deferral record - each location
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
181021 CFR 211.160(a)Lab controls established, including changes
202721 CFR 211.192Investigations of discrepancies, failures
20821 CFR 640.3(a)(1)Donor suitability procedures not followed
22421 CFR 640.4(f)Arm preparation
22721 CFR 640.4(h)Storage temperatures after collection
24121 CFR 640.11(b)General requirements - inspection
25321 CFR 640.25(b)(4)Corrective action
324521 CFR 640.61Explanation of hazards
324621 CFR 640.61Obtaining consent in an appropriate manner
360321 CFR 211.160(b)Scientifically sound laboratory controls
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
8421 CFR 606.100(b)(5)Accurate measurement of quantity of blood
8921 CFR 606.100(b)(10)Controlling storage temperatures
900121 CFR 211.22(a)Lack of quality control unit
923421 CFR 630.40(c)Notification w/in 8 weeks
923521 CFR 630.40(c)Documentation
924321 CFR 630.40(a)Notification
959621 CFR 640.3(a)Donor suitability by means of medical history
9821 CFR 606.100(c)Thorough investigations